Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Mechanisms of Drug Resistance in Veterinary Oncology- A Review with an Emphasis on Canine Lymphoma.

Zandvliet M, Teske E.

Vet Sci. 2015 Aug 12;2(3):150-184. doi: 10.3390/vetsci2030150. Review.

2.

Regulatory roles of glutathione-S-transferases and 4-hydroxynonenal in stress-mediated signaling and toxicity.

Awasthi YC, Ramana KV, Chaudhary P, Srivastava SK, Awasthi S.

Free Radic Biol Med. 2017 Oct;111:235-243. doi: 10.1016/j.freeradbiomed.2016.10.493. Epub 2016 Oct 26. Review.

PMID:
27794453
3.

Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific.

Woolston A, Sintupisut N, Lu TP, Lai LC, Tsai MH, Chuang EY, Yeang CH.

Oncotarget. 2015 Aug 14;6(23):19483-99.

4.

Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.

Goldfinger LE, Lee S.

Lung Cancer (Auckl). 2013;2013(4):61-69.

5.

Oxidative stress and lipid peroxidation products in cancer progression and therapy.

Barrera G.

ISRN Oncol. 2012;2012:137289. doi: 10.5402/2012/137289. Epub 2012 Oct 17.

6.

Biological profile of erucin: a new promising anticancer agent from cruciferous vegetables.

Melchini A, Traka MH.

Toxins (Basel). 2010 Apr;2(4):593-612. doi: 10.3390/toxins2040593. Epub 2010 Apr 5. Review.

7.

The metabolic bioactivation of caffeic acid phenethyl ester (CAPE) mediated by tyrosinase selectively inhibits glutathione S-transferase.

Kudugunti SK, Thorsheim H, Yousef MS, Guan L, Moridani MY.

Chem Biol Interact. 2011 Jul 15;192(3):243-56. doi: 10.1016/j.cbi.2011.03.015. Epub 2011 Mar 31.

8.

Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Li H, Nelson CE, Evans BC, Duvall CL.

Curr Pharm Des. 2011;17(3):293-319. Review.

9.

Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Ciccimaro E, Blair IA.

Bioanalysis. 2010 Feb;2(2):311-41. doi: 10.4155/bio.09.185. Review.

10.

RLIP76: a versatile transporter and an emerging target for cancer therapy.

Vatsyayan R, Lelsani PC, Awasthi S, Singhal SS.

Biochem Pharmacol. 2010 Jun 15;79(12):1699-705. doi: 10.1016/j.bcp.2010.01.016. Epub 2010 Jan 25. Review.

11.

Analysis of endogenous glutathione-adducts and their metabolites.

Blair IA.

Biomed Chromatogr. 2010 Jan;24(1):29-38. doi: 10.1002/bmc.1374. Review.

12.

RLIP76: A novel glutathione-conjugate and multi-drug transporter.

Singhal SS, Yadav S, Roth C, Singhal J.

Biochem Pharmacol. 2009 Mar 1;77(5):761-9. doi: 10.1016/j.bcp.2008.10.006. Epub 2008 Oct 15. Review.

13.

Redox regulation of multidrug resistance in cancer chemotherapy: molecular mechanisms and therapeutic opportunities.

Kuo MT.

Antioxid Redox Signal. 2009 Jan;11(1):99-133. doi: 10.1089/ars.2008.2095. Review.

14.

RLIP76 and Cancer.

Awasthi S, Singhal SS, Awasthi YC, Martin B, Woo JH, Cunningham CC, Frankel AE.

Clin Cancer Res. 2008 Jul 15;14(14):4372-7. doi: 10.1158/1078-0432.CCR-08-0145. Review.

15.

Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.

Singhal SS, Yadav S, Drake K, Singhal J, Awasthi S.

J Biol Chem. 2008 Jul 11;283(28):19714-29. doi: 10.1074/jbc.M708703200. Epub 2008 May 12.

Supplemental Content

Support Center